DK0712926T3 - Virus, der forårsager bugspytkirtelsygdom hos fisk - Google Patents

Virus, der forårsager bugspytkirtelsygdom hos fisk

Info

Publication number: DK0712926T3
Authority: DK; Denmark
Prior art keywords: virus; fish; pancreatic disease; virus causing; causing pancreatic
Prior art date: 1994-10-18

Application number

DK95202771T

Other languages

English (en)

Inventor

Marian F Mcloughlin

Robert Thomas Nelson

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-18

Filing date

1995-10-13

Publication date

2004-02-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0712926(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-18 Priority claimed from GB9420956A external-priority patent/GB9420956D0/en

1995-04-28 Priority claimed from GBGB9508704.5A external-priority patent/GB9508704D0/en

1995-05-10 Priority claimed from GBGB9509425.6A external-priority patent/GB9509425D0/en

1995-10-13 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2004-02-09 Application granted granted Critical

2004-02-09 Publication of DK0712926T3 publication Critical patent/DK0712926T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Hematology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Urology & Nephrology (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Tropical Medicine & Parasitology (AREA)
Cell Biology (AREA)
Mycology (AREA)
Communicable Diseases (AREA)
General Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Oncology (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)

DK95202771T 1994-10-18 1995-10-13 Virus, der forårsager bugspytkirtelsygdom hos fisk DK0712926T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9420956A GB9420956D0 (en)	1994-10-18	1994-10-18	Virus
GBGB9508704.5A GB9508704D0 (en)	1995-04-28	1995-04-28	Virus
GBGB9509425.6A GB9509425D0 (en)	1995-05-10	1995-05-10	"Virus"

Publications (1)

Publication Number	Publication Date
DK0712926T3 true DK0712926T3 (da)	2004-02-09

Family

ID=27267435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95202771T DK0712926T3 (da)	1994-10-18	1995-10-13	Virus, der forårsager bugspytkirtelsygdom hos fisk

Country Status (9)

Country	Link
US (2)	US5939073A (da)
EP (1)	EP0712926B1 (da)
JP (1)	JP3676449B2 (da)
AT (1)	ATE251667T1 (da)
CA (1)	CA2160764C (da)
DE (1)	DE69531891D1 (da)
DK (1)	DK0712926T3 (da)
NO (2)	NO317547B1 (da)
PT (1)	PT712926E (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69432199T2 (de) *	1993-05-24	2004-01-08	Sun Microsystems, Inc., Mountain View	Graphische Benutzerschnittstelle mit Verfahren zur Schnittstellebildung mit fernsteuernden Einrichtungen
DE69936774D1 (de)	1998-05-08	2007-09-20	Intervet Int Bv	Strukturproteine des virus, welches die pankreas-krankheit bei fischen verursacht, und ihre verwendungen
US20030108901A1 (en) *	2001-07-17	2003-06-12	Kibenge Frederick S.B.	Serological test for ISAV in fish
WO2003013597A1 (en) *	2001-08-10	2003-02-20	University Of Maryland Biotechnology Institute	Sub-unit vaccine for infectious pancreatic necrosis virus
WO2005035558A2 (en)	2003-10-07	2005-04-21	Michel Thiry	Piscirickettsia salmonis antigens and use thereof
DK179025B1 (da)	2005-09-16	2017-08-28	Intervet Int Bv	Fiskevaccine
NZ578541A (en)	2006-12-22	2012-04-27	Soluciones Biotecnologicas Innovacion Ltda	Dna vaccines for fish
US7811583B2 (en)	2007-12-19	2010-10-12	Intervet International B.V.	Antigens and vaccines against Piscirickettsia salmonis
NO333242B1 (no) *	2008-02-08	2013-04-15	Pharmaq As	Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus
NO346489B1 (no) *	2008-02-08	2022-09-05	Pharmaq As	Anvendelse av inaktivert SAV i fremstilling av en vaksine.
EP2658866B1 (en) *	2010-12-29	2016-05-25	Intervet International B.V.	Salmonid alphavirus protein e2
WO2012130723A1 (en)	2011-03-25	2012-10-04	Intervet International B.V.	Salmonid alphavirus vaccine
EP3037823A1 (en)	2014-12-22	2016-06-29	BioMar Group A/S	Method for determining pathological tissue damage and diagnosing infectious disease in fish
KR102163242B1 (ko) *	2018-06-05	2020-10-08	전남대학교산학협력단	무지개송어의 면역글로불린 m에 특이적인 단클론항체 및 이의 용도
NO344938B1 (en)	2018-12-13	2020-07-20	Patogen As	Pancreas Disease Virus Markers
CN113122510A (zh) *	2021-04-12	2021-07-16	中国水产科学研究院黑龙江水产研究所	一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5165925A (en) *	1989-05-02	1992-11-24	State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University	Vaccine for immunizing fish against infectious pancreatic necrosis virus

1995
- 1995-10-13 PT PT95202771T patent/PT712926E/pt unknown
- 1995-10-13 EP EP95202771A patent/EP0712926B1/en not_active Expired - Lifetime
- 1995-10-13 DK DK95202771T patent/DK0712926T3/da active
- 1995-10-13 AT AT95202771T patent/ATE251667T1/de active
- 1995-10-13 DE DE69531891T patent/DE69531891D1/de not_active Expired - Lifetime
- 1995-10-17 NO NO19954135A patent/NO317547B1/no not_active IP Right Cessation
- 1995-10-17 CA CA002160764A patent/CA2160764C/en not_active Expired - Lifetime
- 1995-10-18 JP JP27017295A patent/JP3676449B2/ja not_active Expired - Lifetime
- 1995-10-18 US US08/544,681 patent/US5939073A/en not_active Expired - Lifetime
1997
- 1997-05-08 US US08/854,057 patent/US5914260A/en not_active Expired - Lifetime
2011
- 2011-10-28 NO NO2011024C patent/NO2011024I2/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0712926A2 (en)	1996-05-22
US5939073A (en)	1999-08-17
US5914260A (en)	1999-06-22
JPH08228770A (ja)	1996-09-10
CA2160764C (en)	2002-09-03
ATE251667T1 (de)	2003-10-15
PT712926E (pt)	2004-02-27
NO954135D0 (no)	1995-10-17
EP0712926A3 (da)	1996-07-03
CA2160764A1 (en)	1996-04-19
EP0712926B1 (en)	2003-10-08
NO2011024I1 (no)	2011-11-14
DE69531891D1 (de)	2003-11-13
NO317547B1 (no)	2004-11-15
NO954135L (no)	1996-04-19
JP3676449B2 (ja)	2005-07-27
NO2011024I2 (no)	2015-09-07

Publication	Publication Date	Title
DK0712926T3 (da)	2004-02-09	Virus, der forårsager bugspytkirtelsygdom hos fisk
DK0784483T3 (da)	2001-03-26	Præparat indeholdende et rekombinant virus, der udtrykker et antigen, og et rekombinant virus, der udtrykker et immunstimul
DE69637914D1 (de)	2009-06-10	Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
DE69536039D1 (de)	2010-02-11	Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
EA200401405A1 (ru)	2005-04-28	Модифицированный осповакцинный вирус анкара для вакцинации новорожденных
EP0773295A3 (en)	1999-06-16	DNA-based vaccination of fish by immersion
DK1165791T3 (da)	2008-02-11	Humant cytokin som zalpha-receptor-ligand og anvendelse deraf
DK0751992T3 (da)	2006-03-06	Karendotelvækstfaktor 2
DE69829668D1 (de)	2005-05-12	Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
ATE411043T1 (de)	2008-10-15	Verfahren von dna-impfung
KR900700505A (ko)	1990-08-13	폐포계면활성 단백질
ZA923321B (en)	1993-01-27	Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus
ATE237691T1 (de)	2003-05-15	Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
EP0397560A3 (en)	1991-06-05	Spheroidin dna isolate and recombinant entomopoxvirus expression vectors
DE3751727D1 (de)	1996-04-11	Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
DK1075523T3 (da)	2007-12-27	Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
ES2061850T3 (es)	1994-12-16	Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna.
HU9200583D0 (en)	1992-05-28	Method for producing el peptides of rubeola
PL307170A1 (en)	1995-05-15	Vaccine against multicellular parasites
FI885025A0 (fi)	1988-11-01	Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
CA2284110A1 (en)	1998-09-17	An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
NO942075L (no)	1994-08-03	Rekombinante virus omfattende kunstig proteolytisk spaltingssete
JPS6471488A (en)	1989-03-16	Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents
IS3511A7 (is)	1990-04-13	Fjölpeptíð framleidd með aðferðum líftækninnar, kjarnsýrur sem samsvara þeim, og notkun fjölpeptíðanna sem bóluefnis gegn VHS veiru í fiski
NO875151D0 (no)	1987-12-10	Sorteringsrist for levende fisk.